LYSOSOMAL PHOSPHOLIPASE A2 (LPLA2) ACTIVITY AS A DIAGNOSTIC AND THERAPEUTIC TARGET FOR IDENTIFYING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSIS
摘要
The present invention is directed to methods for diagnosis and treatment of systemic lupus erythematosus and drug-induced systemic lupus erythematosus. More specifically, the specification describes methods using a lysosomal phospholipase A2 in methods for the diagnosis and treatment of autoimmune disorders such as systemic lupus erythematosus and drug-induced systemic lupus erythematosus.
申请公布号
WO2010002895(A3)
申请公布日期
2010.05.06
申请号
WO2009US49261
申请日期
2009.06.30
申请人
THE REGENTS OF THE UNIVERSITY OF MICHIGAN;SHAYMAN, JAMES, A.;ABE, AKIRA;KELLY, ROBERT;KOLLMEYER, JESSICA;LU, YE
发明人
SHAYMAN, JAMES, A.;ABE, AKIRA;KELLY, ROBERT;KOLLMEYER, JESSICA;LU, YE